Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2020) 70 EP554 | DOI: 10.1530/endoabs.70.EP554

ECE2020 ePoster Presentations Hot topics (including COVID-19) (57 abstracts)

Patient reported changes in metabolic health during COVID-19 induced lockdown – a cross sectional digital connect survey in type 2 diabetes

Rajiv Kovil 1 , Tejas Shah 2 , Manoj Chawla 3 , Shefali Karkhanis 4 , Dakshata Padhye 5 , Ami Sanghvi 6 , Mayura Kale 7 , Purvi Chawla 3 , Nikhil Prabhu 8 , Vinay Dhandhania 9 & Kiran Shah 10


1Dr. Kovil’s Diabetes Care Centre; 2IVA Diabetes Center; 3Lina Diabetes Care Center; 4Karkhanis Hospital, India; 5Conquer Diabetes Center; 6Sanghvi Eye and Diabetes Care Centre; 7Dr.Kale’s Diabetes and Psychiatry Clinic; 8Dr Nikhil Prabhu’s Diabetes Clinic; 9Bombay Medical Hall; 10Diabetes and Thyroid Care Centre


Introduction: During the COVID-19 induced lockdown it is imperative that people with T2DM be aware, disciplined, and sensitive to achieve glycemic control to mitigate the risks of COVID 19.

Methods: We conducted a cross sectional survey to map the overall short-term impact of nationwide lockdown on the metabolic parameters and change in healthful behaviour patterns among patients from pooled practices of 21 diabetologists across 343 patients, with 30 questions designed to assess the current health status, perceived health status and behaviour before the lockdown and change observed in health status after 21 days of lockdown.

Results: Mean age was 55 years ± 13.0 (95% CI 52 to 55). Participants in aged 18–60 years were more often primary earning members (n = 176) as compared to age group > 60 years (n = 57) (OR 2.48, 95% CI 1.53 to 4.02; P< 0.0003) and less likely to have duration of diabetes > 10 years (n = 80) (OR 0.10 95% CI 0.06 to 0.17, P < 0.0001). Almost half were non-hypertensives (n = 157) between age group of 18–60 years (OR 5.46 95% CI 3.28 to 9.06, P < 0.0001). There was not much change in number of participants aged > 60 years, that had adequate sleep duration even during lockdown (32 vs 33) (OR 0.32 95% CI 0.17 to 0.62, P < 0.0009), whereas almost one fourth (n = 88) who had adequate sleep duration during lockdown were aged 18–60 years. There were less proportion of females (n = 51) on insulin as compared to males (n = 65) (OR 0.44 95% CI 0.28 to 0.71, P < 0.0009). There was dramatic drop in females (105 vs 5) ordering food from eatery as compared to males (205 vs 28) (OR 0.34 95% CI 0.14 to 0.9, P = 0.03). Fasting glucose reported by SMBG > 140 mg/dl, by 32.6% before lockdown, changed to 18%, during lockdown. Participants reporting decrease in weight (16.3%) were more than those reporting increase in weight (14.8%), despite 7.7% less participants reporting daily physical exercise during lockdown. There were 81% and 74% increase in people who were unable to SMBG for fasting and post prandial glucose, respectively.

Conclusions: Our study highlights the dynamic impact of the lockdown which enabled a situational, self-automated patient empowerment driven despite limited resources, to enable control of diabetes. The results need corroboration with a longer follow up to evaluate changes with the evolving COVID 19 environment.

Volume 70

22nd European Congress of Endocrinology

Online
05 Sep 2020 - 09 Sep 2020

European Society of Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches.